{
    "nct_id": "NCT03085147",
    "official_title": "A Phase I/II Study of the Fluorescent PARP1 Binding Imaging Agent PARPi-FL in Patients With Oral Squamous Cell Carcinomas",
    "inclusion_criteria": "* Patient is â‰¥ 18 years old\n* Histologically or cytologically proven squamous cell carcinoma of the oral cavity or pharynx (OSCC)\n* Scheduled to undergo surgery at MSK\n* Any tumor stage, any N, M0\n* ECOG performance status 0 or 1\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Any surgical therapy in the area of the oral cavity or pharynx within the last 2 weeks\n* Prior or ongoing treatment with a PARP1 inhibitor\n* Known hypersensitivity to Olaparib\n* Known hypersensitivity to PEG Eligibility criteria will be assessed by an experienced oral surgeon, typically the Co-PI of the study.",
    "miscellaneous_criteria": ""
}